Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to mee...
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid
- Merck & Co Inc said on Monday its blockbuster cancer drug Keytruda failed to meet the main goal of a late-stage study testing the drug as a standalone treatment in patients with an aggressive type of breast cancer.Keytruda, among a class of medicines called PD-1 inhibitors, did not meet the main goal of helping patients live longer, when compared to chemotherapy.
The treatment will continue to be studied in earlier stages of the disease and in combination with chemotherapy in patients with triple negative breast cancer, the company said. Triple negative breast cancer occurs in about 10% to 20% of breast cancer patients and is more difficult to treat, the company said.
Keytruda, which brought in sales of $2.27 billion for the company in the first quarter, has U.S. approval for other forms of cancer including skin and lung cancer.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Supreme Court gives Merck another shot to avoid Fosamax lawsuitsThe U.S. Supreme Court on Monday gave Merck & Co a new opportunity to avoid laws...
Baca lebih lajut »
U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drugSupreme Court rules for Merck on claims it failed to warn about fracture risk from osteoporosis drug Fosamax
Baca lebih lajut »
Supreme Court blocks bid to sue Merck over Fosamax bone fracturesSupreme Court unanimously blocks, for now, a class-action lawsuit against pharmaceutical giant Merck over 'atypical femoral fractures' caused by osteoporosis drug Fosamax.
Baca lebih lajut »
Low-fat diet can reduce risk of breast cancer, new study findsA big, new study found that women eating a low-fat diet now could had a significantly lower risk of dying from breast cancer later in life. NBC medical correspondent Dr. John Torres joins TODAY to share more about the findings and ways to tweak your diet.
Baca lebih lajut »
Lower-fat diet reduces women’s risk of dying from breast cancer, study says
Baca lebih lajut »
Low-fat diet helps reduce risk of dying from breast cancer, study findsEating a low-fat, plant-based diet could help significantly lower a woman's risk of dying from breast cancer, according to a study.
Baca lebih lajut »
U.S. Supreme Court tosses ruling against Merck on Fosamax osteoporosis drugSupreme Court rules for Merck on claims it failed to warn about fracture risk from osteoporosis drug Fosamax
Baca lebih lajut »
Supreme Court blocks bid to sue Merck over Fosamax bone fracturesSupreme Court unanimously blocks, for now, a class-action lawsuit against pharmaceutical giant Merck over 'atypical femoral fractures' caused by osteoporosis drug Fosamax.
Baca lebih lajut »
Supreme Court gives Merck another shot to avoid Fosamax lawsuitsThe U.S. Supreme Court on Monday gave Merck & Co a new opportunity to avoid laws...
Baca lebih lajut »